1. Recent Findings in the Regulation of Programmed Death Ligand 1 Expression
   Xiangfeng Shen et al, 2019, Front. Immunol. CrossRef
2. Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
   Alexandre Perrier et al, 2020, Biomolecules CrossRef
3. Spatial and Temporal Changes in PD-L1 Expression in Cancer: The Role of Genetic Drivers, Tumor Microenvironment and Resistance to Therapy
   Elena Shklovskaya et al, 2020, IJMS CrossRef
4. The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?
   Giuseppe Lamberti et al, 2020, Cancers CrossRef
5. Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer.
   Young-Ho Ahn et al, 2020, Int J Mol Sci CrossRef
6. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers
   Asal Jalal Abadi et al, 2021, Biomolecules CrossRef
7. Circular RNA hsa_circ_0000190 Facilitates the Tumorigenesis and Immune Evasion by Upregulating the Expression of Soluble PD-L1 in Non-Small-Cell Lung Cancer
   Yung-Hung Luo et al, 2021, IJMS CrossRef
8. β-Elemene Restrains PTEN mRNA Degradation to Restrain the Growth of Lung Cancer Cells via METTL3-Mediated N6 Methyladenosine Modification
   Yuxu Feng et al, 2022, Journal of Oncology CrossRef
9. A Four-miRNA-Based Diagnostic Signature for Rheumatoid Arthritis
   Xu Jiang et al, 2022, Disease Markers CrossRef
10. Metabolomics Based on Peripheral Blood Mononuclear Cells to Dissect the Mechanisms of Chaigui Granules for Treating Depression
    Dehua Huang et al, 2022, ACS Omega CrossRef
11. Roles of PTEN inactivation and PD-1/PD-L1 activation in esophageal squamous cell carcinoma
    Rong Qiu et al, 2022, Mol Biol Rep CrossRef
12. MicroRNAs: Key Regulators in Lung Cancer
    Younes El Founini et al, 2021, MIRNA CrossRef
13. miR-142-5p Encapsulated by Serum-Derived Extracellular Vesicles Protects against Acute Lung Injury in Septic Rats following Remote Ischemic Preconditioning via the PTEN/PI3K/Akt Axis
    Wenliang Zhu et al, 2022, J Innate Immun CrossRef
14. The Regulatory Effects of MicroRNAs on Tumor Immunity
    Yan Lu et al, 2022, BioMed Research International CrossRef
15. null
    Oxana V. Klimenko et al, 2022 CrossRef
16. A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study
    Mahdi Abdoli Shadbad et al, 2022, Front. Med. CrossRef
17. Interplay between programmed death-ligand 1 and non-coding RNAs
    Soudeh Ghafouri-Fard et al, 2022, Front. Immunol. CrossRef
18. Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitors
    Ying Liang et al, 2023, Front. Immunol. CrossRef
19. Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer
    Yanting Wang et al, 2023, Front. Oncol. CrossRef